Harbor Capital Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Buy |
33,472
+2,594
| +8% | +$113K | 0.06% | 377 |
|
|
2025
Q1 | $845K | Sell |
30,878
-10,109
| -25% | -$277K | 0.04% | 461 |
|
|
2024
Q4 | $1.65M | Buy |
40,987
+684
| +2% | +$27.5K | 0.07% | 346 |
|
|
2024
Q3 | $1.91M | Buy |
40,303
+9,292
| +30% | +$440K | 0.08% | 309 |
|
|
2024
Q2 | $926K | Sell |
31,011
-10,321
| -25% | -$308K | 0.07% | 378 |
|
|
2024
Q1 | $1.66M | Buy |
41,332
+6,691
| +19% | +$269K | 0.22% | 110 |
|
|
2023
Q4 | $882K | Sell |
34,641
-570
| -2% | -$14.5K | 0.17% | 155 |
|
|
2023
Q3 | $489K | Buy |
35,211
+3,834
| +12% | +$53.3K | 0.1% | 231 |
|
|
2023
Q2 | $721K | Buy |
31,377
+20,059
| +177% | +$461K | 0.14% | 185 |
|
|
2023
Q1 | $335K | Sell |
11,318
-360
| -3% | -$10.7K | 0.1% | 175 |
|
|
2022
Q4 | $291K | Sell |
11,678
-247
| -2% | -$6.17K | 0.28% | 73 |
|
|
2022
Q3 | $260K | Sell |
11,925
-340
| -3% | -$7.41K | 0.24% | 77 |
|
|
2022
Q2 | $241K | Sell |
12,265
-1,730
| -12% | -$34K | 0.18% | 79 |
|
|
2022
Q1 | $592K | Sell |
13,995
-2,856
| -17% | -$121K | 0.28% | 75 |
|
|
2021
Q4 | $1.07M | Buy |
+16,851
| New | +$1.07M | 0.39% | 69 |
|